Editorial: Research and updates in veterinary transfusion medicine
Shauna L. Blois+2 more
doaj +1 more source
Alterations in blood component utilization in a tertiary care hospital in eastern India in the COVID-19 pandemic. [PDF]
Das SS, Biswas RN.
europepmc +1 more source
Irradiated Blood Components [PDF]
Harold A. Oberman+6 more
openaire +2 more sources
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau+9 more
wiley +1 more source
Computational modeling of blood component transport related to coronary artery thrombosis in Kawasaki disease. [PDF]
Grande Gutiérrez N+6 more
europepmc +1 more source
THE EFFECTS ON BLOOD-PRESSURE OF INTRAVENOUS INJECTIONS OF EXTRACTS OF THE VARIOUS ANATOMICAL COMPONENTS OF THE HYPOPHYSIS [PDF]
DEAN LEWIS
openalex +1 more source
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald+18 more
wiley +1 more source
Objective This study aims to evaluate the clinical significance of ultrasound-based measurement of optic nerve sheath diameter (ONSD) in predicting intracerebral hemorrhage (ICH) complicated by cerebral-cardiac syndrome (CCS).
Wei-Ze Fan+7 more
doaj +1 more source
Reducing the risk of transfusion-transmitted infectious disease markers in blood and blood component donations: Movement from remunerated to voluntary, non-remunerated donations in Lithuania from 2013 to 2020. [PDF]
Kalibatas V, Kalibatienė L.
europepmc +1 more source
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias+12 more
wiley +1 more source